SING GEORGE L
Reporting owner on Forms 3, 4 and 5, CIK 1225471.
SING GEORGE L reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-18.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| REGN · REGENERON PHARMACEUTICALS, INC.CIK 872589 | director | 2 | 2026-11-18 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-17 | S sold | -176 | $956.96 | 23,971 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-17 | S sold | -359 | $957.49 | 23,612 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-17 | S sold | -465 | $958.11 | 23,147 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-16 | S sold | -1,000 | $960.26 | 24,147 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 750 | Form 4 | ||||
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 400 | Form 4 | ||||
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 1,000 | Form 4 | ||||
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | M exercised | +7,830 | $376.69 | 38,837 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | M exercised | +7,439 | $380.95 | 46,276 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | S sold | -1,224 | $960.57 | 45,052 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | S sold | -540 | $961.85 | 44,512 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | S sold | -2,522 | $962.61 | 41,990 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | S sold | -4,338 | $963.47 | 37,652 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | S sold | -2,670 | $964.57 | 34,982 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | S sold | -7,073 | $965.38 | 27,909 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | S sold | -1,522 | $966.27 | 26,387 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | S sold | -1,040 | $967.07 | 25,347 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | S sold | -200 | $970.18 | 25,147 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 750 | Form 4 | ||||
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 400 | Form 4 | ||||
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 1,000 | Form 4 | ||||
| REGN · REGENERON PHARMACEUTICALS, …Non-Qualified Stock Option (right to bu…, derivative | 2026-11-02 | M exercised | -7,830 | $0 | 0 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Non-Qualified Stock Option (right to bu…, derivative | 2026-11-02 | M exercised | -7,439 | $0 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001225471-26-000006 | REGENERON PHARMACEUTICALS, INC. | 2026-11-18 | ||
| Form 4 0001225471-26-000004 | REGENERON PHARMACEUTICALS, INC. | 2026-11-04 |